Genome-wide association study (GWAS) of efficacy and safety endpoints in pazopanib- or sunitinib-treated patients with renal cell carcinoma (RCC) Meeting Abstract
| Authors: | Johnson, T.; Xu, C. F.; Choueiri, T. K.; Figlin, R. A.; Sternberg, C. N.; King, K. S.; Xue, Z. Y.; Stinnett, S.; Deen, K. C.; Carpenter, C.; Spraggs, C. F.; Bartlett-Pandite, A. N.; Motzer, R. J. |
| Abstract Title: | Genome-wide association study (GWAS) of efficacy and safety endpoints in pazopanib- or sunitinib-treated patients with renal cell carcinoma (RCC) |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613203309 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.4503 |
| Notes: | Meeting Abstract: 4503 -- Source: Wos |
